IRADIMED (IRMD) Reports Q2 EPS of $0.13
Tweet
Share
E-mailGet Alerts IRMD Hot Sheet
Join SI Premium – FREE
IRADIMED (NASDAQ: IRMD) reported Q2 EPS of $0.13, versus $0.07 reported last year. Revenue for the quarter came in at $4.7 million, versus $2.8 million reported last year.
For earnings history and earnings-related data on IRADIMED (IRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James upgrades Ralph Lauren on stronger growth outlook ahead of earnings
- PharmaTher partners with KetaMist inventor to seek FDA approval
- Mueller Industries (MLI) Tops Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
